Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

breast cancer month ribbon

Breast cancer rates are on the rise, new report reveals

This week, the American Cancer Society’s annual Breast Cancer Statistics report revealed several eye-opening figures.

Post-mastectomy radiation therapy can be safely shortened prior to breast reconstruction

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road. 

Thumbnail

MRI-guided biopsy decisions halve the rate of clinically insignificant prostate cancer diagnoses

“This paper is the message to healthcare authorities around the world to look over recommendations for men."

CT findings linked with pancreatic cancer

CT findings linked to heightened risk of pancreatic cancer recurrence

In 2023, the Society of Abdominal Radiology released its consensus statement regarding follow-up imaging of patients who have had their cancer surgically resected.

Thumbnail

New research argues for MRI in all prostate cancer patients, even those considered low-risk

The study's findings indicate that obtaining a prostate MRI at the time of a patient's initial diagnosis may provide important insight into how cancer will progress over time.

FAPI PET improves staging and clinical management for a significant portion of pancreatic cancers

Fibroblast activation protein inhibitor PET imaging may provide more accurate insight into the spread of pancreatic cancer than more commonly used 18F-FDG PET/CT.

Thumbnail

Reducing prostate cancer treatment dosage alleviates downsides while remaining effective

Reducing certain treatments by around 25% and 50% still achieves promising PSA response rates, but reduces some of the unwanted side effects of therapy, like dry mouth. 

Thumbnail

Researchers score $2M to examine side effects of radiation therapy in prostate cancer patients

The grant will fund a team at the UCLA Health Jonsson Comprehensive Cancer Center working to identify genetic biomarkers capable of predicting RT side effects.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup